Jeeva launched an innovative program on Aug. 1, 2023, to support early phase innovation in the “US Emerging Biopharma and medical device industry,” struggling to cope with the short-term effects of the Inflation Reduction Act 2022.
Jeeva is proud to offer an affordable and comprehensive solution for academic principal investigators, supporting them from the initial protocol proposal preparation phase to publication.
Most clinical trials are sponsored and conducted in the US and EU. 90% of the world's population is minimally engaged or cannot access life-saving therapies in clinical trials. Even within the US and EU, about 95% of the population lives far away from the medical research hospitals where clinical trials are conducted and hence have been underserved.
FDA has now required biopharmaceutical companies to include a racial and ethnic diversity plan (REDP) in their IND submissions. The FDA has issued guidance to the industry on what is expected in this plan for ensuring all racial and ethnic populations are proportionally represented in their clinical trials across all phases based on the prevalence of the disease under investigation.
Jeeva's medical writing and clinical investigators collaborate with clinical trial sponsors to assist with all protocol design and writing aspects, including turnkey services.
Jeeva Trials offers comprehensive biostatistics services backed by expertise and experience. Our team of experts leverages advanced statistical methods and techniques to ensure accurate analysis and interpretation of your clinical trial data, providing valuable insights to drive successful research outcomes.
Our clinical trial data management services offer effective and dependable solutions to enhance research processes. We ensure precise collection, organization, and data analysis, resulting in successful clinical trials.
Still Curious If Jeeva eClinical Cloud is a Good Fit for Your Study?
Jeeva eClinical Cloud is designed to be disease-agnostic, device-agnostic, flexible, and modular to support patient-preferred decentralized or hybrid trial operations. Schedule a 30-minute call today to determine the fit. We will help you identify gaps in technology or protocol complexity to enable an informed decision.
